130 related articles for article (PubMed ID: 38669912)
41. In vitro antitumor activity, metal uptake and reactivity with ascorbic acid and BSA of some gold(III) complexes with N,N'-ethylenediamine bidentate ester ligands.
Pantelić N; Zmejkovski BB; Kolundžija B; Crnogorac MĐ; Vujić JM; Dojčinović B; Trifunović SR; Stanojković TP; Sabo TJ; Kaluđerović GN
J Inorg Biochem; 2017 Jul; 172():55-66. PubMed ID: 28433833
[TBL] [Abstract][Full Text] [Related]
42. Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents.
Li J; Tian Z; Xu Z; Zhang S; Feng Y; Zhang L; Liu Z
Dalton Trans; 2018 Nov; 47(44):15772-15782. PubMed ID: 30357192
[TBL] [Abstract][Full Text] [Related]
43. Half-sandwich ruthenium(ii) complexes containing N^N-chelated imino-pyridyl ligands that are selectively toxic to cancer cells.
Tian M; Li J; Zhang S; Guo L; He X; Kong D; Zhang H; Liu Z
Chem Commun (Camb); 2017 Nov; 53(95):12810-12813. PubMed ID: 29143019
[TBL] [Abstract][Full Text] [Related]
44. Novel platinum(II) compounds with O,S bidentate ligands: synthesis, characterization, antiproliferative properties and biomolecular interactions.
Mügge C; Liu R; Görls H; Gabbiani C; Michelucci E; Rüdiger N; Clement JH; Messori L; Weigand W
Dalton Trans; 2014 Feb; 43(8):3072-86. PubMed ID: 24169734
[TBL] [Abstract][Full Text] [Related]
45. Highly Cytotoxic Osmium(II) Compounds and Their Ruthenium(II) Analogues Targeting Ovarian Carcinoma Cell Lines and Evading Cisplatin Resistance Mechanisms.
Hildebrandt J; Häfner N; Kritsch D; Görls H; Dürst M; Runnebaum IB; Weigand W
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563367
[TBL] [Abstract][Full Text] [Related]
46. Effect of
Mukherjee A; Acharya S; Purkait K; Chakraborty K; Bhattacharjee A; Mukherjee A
Inorg Chem; 2020 May; 59(9):6581-6594. PubMed ID: 32295347
[TBL] [Abstract][Full Text] [Related]
47. A nine-coordinated bismuth(III) complex derived from pentadentate 2,6-diacetylpyridine bis((4)N-methylthiosemicarbazone): crystal structure and both in vitro and in vivo biological evaluation.
Li MX; Yang M; Niu JY; Zhang LZ; Xie SQ
Inorg Chem; 2012 Nov; 51(22):12521-6. PubMed ID: 23136979
[TBL] [Abstract][Full Text] [Related]
48. Synthesis, X-ray structure, physicochemical properties and anticancer activity of mer and fac Ru(iii) triphenylphosphine complexes with a benzothiazole derivative as a co-ligand.
Richert M; Walczyk M; Cieślak MJ; Kaźmierczak-Barańska J; Królewska-Golińska K; Wrzeszcz G; Muzioł T; Biniak S
Dalton Trans; 2019 Jul; 48(28):10689-10702. PubMed ID: 31241117
[TBL] [Abstract][Full Text] [Related]
49. Reactive Oxygen Species Production Is Responsible for Antineoplastic Activity of Osmium, Ruthenium, Iridium and Rhodium Half-Sandwich Type Complexes with Bidentate Glycosyl Heterocyclic Ligands in Various Cancer Cell Models.
Kacsir I; Sipos A; Bényei A; Janka E; Buglyó P; Somsák L; Bai P; Bokor É
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054999
[TBL] [Abstract][Full Text] [Related]
50. Alkyl chain-modified cyclometalated iridium complexes as tunable anticancer and imaging agents.
Laha P; De U; Chandra F; Dehury N; Khullar S; Kim HS; Patra S
Dalton Trans; 2018 Nov; 47(44):15873-15881. PubMed ID: 30358775
[TBL] [Abstract][Full Text] [Related]
51. Synthesis, characterization and anticancer mechanism studies of fluorinated cyclometalated ruthenium(ii) complexes.
Wen Y; Ouyang C; Li Q; Rees TW; Qiu K; Ji L; Chao H
Dalton Trans; 2020 Jun; 49(21):7044-7052. PubMed ID: 32406463
[TBL] [Abstract][Full Text] [Related]
52. Synthesis, crystal structures and spectroscopy of meclofenamic acid and its metal complexes with manganese(II), copper(II), zinc(II) and cadmium(II). Antiproliferative and superoxide dismutase activity.
Kovala-Demertzi D; Staninska M; Garcia-Santos I; Castineiras A; Demertzis MA
J Inorg Biochem; 2011 Sep; 105(9):1187-95. PubMed ID: 21718655
[TBL] [Abstract][Full Text] [Related]
53. Platinum(II) and Copper(II) complexes of asymmetric halogen-substituted [NN'O] ligands: Synthesis, characterization, structural investigations and antiproliferative activity.
Amiri Rudbari H; Saadati A; Aryaeifar M; Blacque O; Cuevas-Vicario JV; Cabral R; Raposo LR; Fernandes AR
Bioorg Chem; 2022 Feb; 119():105556. PubMed ID: 34959175
[TBL] [Abstract][Full Text] [Related]
54. Exploring the cytotoxicity of dinuclear Ru(II)
Abirami A; Devan U; Ramesh R; Antony Joseph Velanganni A; Małecki JG
Dalton Trans; 2024 Mar; 53(11):5167-5179. PubMed ID: 38380977
[TBL] [Abstract][Full Text] [Related]
55. In vitro nephrotoxicity and anticancer potency of newly synthesized cadmium complexes.
Abyar S; Khandar AA; Salehi R; Abolfazl Hosseini-Yazdi S; Alizadeh E; Mahkam M; Jamalpoor A; White JM; Shojaei M; Aizpurua-Olaizola O; Masereeuw R; Janssen MJ
Sci Rep; 2019 Oct; 9(1):14686. PubMed ID: 31604983
[TBL] [Abstract][Full Text] [Related]
56. Efficient hydrolytic cleavage of DNA and antiproliferative effect on human cancer cells by two dinuclear Cu(II) complexes containing a carbohydrazone ligand and 1,10-phenanthroline as a coligand.
Parsekar SU; Singh M; Mishra DP; Antharjanam PKS; Koley AP; Kumar M
J Biol Inorg Chem; 2019 May; 24(3):343-363. PubMed ID: 30887122
[TBL] [Abstract][Full Text] [Related]
57. Diorganotin (IV) complexes with 4-nitro-N-phthaloyl-glycine: Synthesis, characterization, antitumor activity and DNA-binding studies.
Yan C; Zhang J; Liang T; Li Q
Biomed Pharmacother; 2015 Apr; 71():119-27. PubMed ID: 25960226
[TBL] [Abstract][Full Text] [Related]
58. New manganese(II), iron(II), cobalt(II), nickel(II) and copper(II) saccharinate complexes of 2,6-bis(2-benzimidazolyl)pyridine as potential anticancer agents.
Icsel C; Yilmaz VT; Aydinlik Ş; Aygun M
Eur J Med Chem; 2020 Sep; 202():112535. PubMed ID: 32653697
[TBL] [Abstract][Full Text] [Related]
59. Anticancer activity of 8-hydroxyquinoline-triphenylphosphine rhodium(III) complexes targeting mitophagy pathways.
Huang XQ; Wu RC; Liang JM; Zhou Z; Qin QP; Liang H
Eur J Med Chem; 2024 Jun; 272():116478. PubMed ID: 38718624
[TBL] [Abstract][Full Text] [Related]
60. Synthesis, molecular structure, computational study and in vitro anticancer activity of dinuclear thiolato-bridged pentamethylcyclopentadienyl Rh(III) and Ir(III) complexes.
Gupta G; Garci A; Murray BS; Dyson PJ; Fabre G; Trouillas P; Giannini F; Furrer J; Süss-Fink G; Therrien B
Dalton Trans; 2013 Nov; 42(43):15457-63. PubMed ID: 24022745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]